Market Research Logo

Brazil Pharmaceuticals and Healthcare Report Q2 2015

144 Pages BMI Research SKU: BMI5478791

Brazil Pharmaceuticals and Healthcare Report Q2 2015

BMI View: Continued regulatory improvements, growing pharmaceutical and healthcare markets, andincreased favour for foreign investment will allow Brazil to maintain its position as the regionaloutperformer in Latin America. However, low affordability and increasing generic drug competition willhamper opportunities for innovative drugmakers as the country continues to develop its economy.

Headline Expenditure Projections

Pharmaceuticals: BRL62.0bn (USD26.3bn) in 2014 to BRL65.3bn (USD25.6bn) in 2015; +5.2% in localcurrency terms and -2.8% in US dollar terms. Forecast in local currency has been maintained from Q115while US dollar growth sees limited development due to depreciating Brazilian Real.

Show Full Description


Show Table of Contents



Brazil Pharmaceuticals and Healthcare Report Q2 2015

BMI Research

Pricing & Delivery

Report with 3 quarterly updates
$1,295
Report with 3 quarterly updates - 3 User License
$1,945
Report with 3 quarterly updates - 5 User License
$2,500
Report with 3 quarterly updates - Departmental/Site License
$2,995
Global Site License Fulfilled by Publisher
$6,995

Didn't find what you are looking for?

Let us find it for you. One of our knowledgeable research assistants will work with you to find exactly the right research to answer your questions:

US: 800.298.5699 International: +1.240.747.3093 Or leave us a message and we'll call you back!

Receive bi-weekly email alerts for new market research.



CTA Image

Download our free eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.


Download CTA

Share this report